The c-Myc is a prolific proto-oncogene involved in several hallmarks of cancer [20], is dysregulated in three fourths of human cancers, and in about 70% of advanced PC but is yet to be successfully targeted [20]. The gene discussed is MYC; the disease is pachyonychia congenita.